The global market is expected to enjoy a valuation of US$ 86.9 Million by the end of the year 2023, and further expand at a CAGR of 9.8% to reach a valuation of ~US$ 244.3 Million by the year 2033. According to the recent study by Future Market Insights, trolley mounted devices are leading the market with an expected share of about 38.7% in the year 2023, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 86.9 Million |
| Market Value 2023 | US$ 95.6 Million |
| Market Value 2033 | US$ 244.3 Million |
| CAGR 2023 to 2033 | 9.8% |
| Market Share of Top 5 Countries | 52.5% |
| Key Market Players List | Biodex Medical Systems, Inc., CAPINTEC, INC., Crystal Photonics GmBH, Devicor Medical Products, Inc (Mammotome), Dilon Technologies, Inc, Gamma Medical Technology, Intramedical Imaging, Intramedical Imaging, KUB Technologies, L'ACN - l'Accessorio Nucleare, Mammotome, NUCLEAR MEDSYSTEMS, Oncovision, and Southern Scientific Ltd. |
The global market for gamma probe devices is being driven by rising public knowledge of the advantages of gamma radiation over conventional detection methods like X-rays, as well as rising patient acceptance and surgeon use of it.
Gamma probe devices support radio guided surgery and diagnosis throughout the pre- and intra-operative phases.
For surgeons, it can be challenging to detect tissues like lymph nodes, tumours, and parathyroid glands within the human body. Therefore, using gamma probe devices properly could enable the surgeon to use a smaller incision to find the desired tissues. Demand will increase during the predicted period due to top cancer centres using gamma probes more routinely.
Increasing focus on product launch by market players, acquisitions they undertake, and surging application in cancer treatments are expected to drive the market growth over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for gamma probe devices was around 1.4% of the overall ~US$ 6.4 Billion of the global radiotherapy devices market in 2022.
The sale of gamma probe devices expanded at a CAGR of 8.3% from 2015 to 2022.
The market for nuclear medicine has expanded due to the rising incidence of cancer worldwide, opening up enormous potential prospects. Healthcare professionals and regulatory agencies have been under pressure to enhance radioisotope manufacturing for use in therapeutic nuclear medications as the death rate from cancer has increased.
The surgeon and nuclear medicine doctor can employ intraoperative gamma probe systems, which are extremely sensitive, as a guidance to locate the radiolabelled sentinel lymph node.
For RSL, gamma probes are primarily used to find tiny, palpable breast lesions. Over the projection period, expanding use of gamma probes as nuclear medicine in oncology will present manufacturers with profitable prospects.
Market leaders are being prompted by growing demand for gamma probe devices in sentinel lymph node uptake operations to diversify their product offerings through tactical acquisitions of smaller businesses. Manufacturers are also concentrating on acquiring new companies to expand their industrial and commercial platforms and global distribution networks.
Thus, owing to the aforementioned factors, the global gamma probe devices market is expected to grow at a CAGR of 9.8% during the forecast period between 2023 and 2033.
H1-H2 Update
| Market Statistics | Details |
|---|---|
| Jan-Jun (H1), 2021 (A) | 7.86% |
| Jul-Dec (H2), 2021 (A) | 11.03% |
| Jan-Jun (H1),2022 Projected (P) | 7.45% |
| Jan-Jun (H1),2022 Outlook (O) | 7.79% |
| Jul-Dec (H2), 2022 Outlook (O) | 11.52% |
| Jul-Dec (H2), 2022 Projected (P) | 10.99% |
| Jan-Jun (H1), 2023 Projected (P) | 8.97% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 34↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (-) 6↓ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 53↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 49↑ |
Improvements in healthcare infrastructure together with increased medical spending by various government organizations have led to increasing number installations of innovative medical technology. The need for gamma probe instruments would go up as a result.
The use of robotic surgery has been prompted by the growing emphasis on striking a balance between cure and side effects, which calls for accurate target definition and control (intraoperative). Radio guided robotic surgery has recently been made easier with the introduction of DROP-IN gamma probes.
The click-on gamma probe's launch, meanwhile, is seen as a step toward the complete integration of radio guidance in surgery. The tethered (DROP-IN) gamma-probe concept enables the detector to match the degrees of freedom of the robotic instruments and facilitates autonomous control by the operating surgeon. This has been confirmed by robotic-assisted sentinel lymph node procedures and PSMA-guided salvage resection of lymph nodes.
The market for gamma probe devices is seeing profitable growth potential because of these developments.
Principal Consultant
The amount of product recalls and strict governmental controls hampered industry expansion. A company's financial situation, business, and operational outcomes gets negatively impacted by a product recall.
For instance, Devicor Medical Products Inc.’s 14 mm reusable probe called NeoProbe Bluetooth was recalled in April 2019 by Health Canada of the Government of Canada.
Another significant barrier to the market for gamma probe devices is anticipated to be patients' rising preference for cost-effective alternatives.
Only those who can afford the cost of the treatment can choose gamma probe devices. One of the main reasons limiting the growth of the gamma probe devices market is that not many healthcare facilities, such as small hospitals and clinics, can afford the high cost of the equipment.
| Country | The USA |
|---|---|
| Market Share (2023) | 22.1% |
| Market Share (2033) | 19.2% |
| BPS Analysis | -295 |
| Country | Germany |
|---|---|
| Market Share (2023) | 10.7% |
| Market Share (2033) | 9.2% |
| BPS Analysis | -146 |
| Country | UK |
|---|---|
| Market Share (2023) | 6.5% |
| Market Share (2033) | 5.9% |
| BPS Analysis | -68 |
| Country | China |
|---|---|
| Market Share (2023) | 6.7% |
| Market Share (2033) | 7.3% |
| BPS Analysis | 60 |
| Country | France |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 5.2% |
| BPS Analysis | -38 |
The USA is set to dominate the globe with a total market share of about 22.1% in 2023, and is expected to continue to experience the same growth throughout the forecast period.
Major players in the US are concentrating on enhancing throughput, flexibility, and productivity. A rising cancer incidence, increased use of nuclear therapy, and technical advancements with new product debuts have all contributed to the market's expansion in the United States.
The market for nucleic therapies has increased in North America because of significant investments in RD and government support for the use of medical isotopes, which has strengthened the gamma probe sector.
Germany will hold a market share of nearly 10.7% in the global gamma probe devices market in 2023.
According to the research and knowledge department of the European Commission, there were around 2.7 million new cases of cancer, which includes all forms of cancer except non-melanoma skin cancer. Additionally, nearly 1.3 million fatalities occurred in Europe in 2020.
These statistics show that men are disproportionately more impacted by cancer than women, accounting for 54% of new cases and 56% of fatalities. As is commonly known, cancer mostly affects elderly people. The predictions for 2020 indicate that 76 percent of fatalities and 62 percent of new diagnoses occur in people over 65.
The Germany gamma probe device market is also being driven forward by the presence of well-established healthcare players and infrastructure as well as rising regional healthcare spending.
China will hold a share of around 6.7% in the global market, in 2023.
The ageing population within the region, good regulatory environment, adoption of new technologies, and high consumer disposable income, brings the market to expand within China.
The market in China is expected to rise over the next several years as a result of an increase in the frequency of chronic conditions that necessitate for surgical procedures, increasing unmet healthcare demand, and improved healthcare infrastructure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Trolley mounted devices are set to hold a share of around 38.7% in the global market, in 2023.
Devices that are mounted on a trolley during procedures considerably increase portability and maneuverability. These tools typically enable data collection, graphical development, patient database organization, and spectrum analysis of any radioactive isotope that may be used. Over the course of the forecast period, these advantages are anticipated to contribute to the growth in the segment value for trolley-mounted devices.
Sentinel lymph node uptake applications are set to hold a market share of around 55.9% in the global market in 2023.
A sentinel node biopsy or sentinel lymph node biopsy (SLNB) is a surgical procedure for cancer patients. This procedure involves removal of the sentinel nodes, later transferred to a lab to be checked for malignant cells. A gamma probe is used during SLNB procedures as a tool to detect radiation in patients. It is mostly used in surgery and functions something like a tiny, directional Geiger counter. Sentinel node biopsy is thus, performed to determine extent of cancer spread.
Hospitals are expected to hold a market share of around 52.0% in the global market in 2023.
There is a growing global incidence of thyroid and glad disorders. Moreover, increasing cases of breast cancer are further propelling hospital in-patient rates, augmenting the segment growth over the forecast period. According to the American Hospital Association (AHA), there were approximately 6,146 hospitals in the United States as of 2018, and that number of new invasive breast cancer cases by 2020 were 276,480. During the forecast period, it is anticipated that this will create more growth opportunities for the gamma probe devices market.
In order to expand their client base and gain market share, medical device companies are concentrating on forming alliances with up-and-coming businesses.
At specialized scientific seminars and conferences, leading market participants advertise their products. It is anticipated that this marketing strategy would have a significant influence on overall expansion of the global market.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the gamma probe devices space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Modality, Application, End User, and Region |
| Key Companies Covered |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The United States, the United Kingdom, and Australia are leading the market.
The hospital industry holds high revenue potential.
The global market is estimated to capture a valuation of US$ 86.9 million in 2023.
The market is forecast to register a CAGR of 9.8% through 2033.
The market recorded a CAGR of 8.3% from 2018 to 2022.
1. Market- Executive Summary | Gamma Probe Devices Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Technology Evolution 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion and Exclusion 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Thyroid and Cancer Epidemiology 4.2. Product Adoption/Usage Analysis 4.3. Product USPs 4.4. Promotional Strategies, By Key Players 4.5. Regulatory Scenario 4.6. Technology Assessment 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Industry Market Outlook 5.1.3. Global Radiotherapy Devices Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Adoption of Universal Health Coverage 5.2.2. Reimbursement Scenario 5.2.3. Regulatory Framework 5.2.4. Recent Advancements In Technology 5.2.5. Rising cancer cases 5.2.6. Growing Adoption of Gamma Probe Devices 5.2.7. Increasing Death Rate Due to Thyroid Cancer 5.2.8. Strategic Agreements Among Key Players to Increase Product Reach 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. 2022 Market Scenario 6.2. COVID19 and Impact Analysis 6.2.1. Revenue By Modality 6.2.2. Revenue By Application 6.2.3. Revenue By End User 6.2.4. Revenue By Country 7. Global Market Demand (in Volume Units) Analysis 2015 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Volume (Units) Analysis, 2015 to 2022 7.2. Current and Future Market Volume (units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Modality 8.2. Pricing Break-up 8.2.1. Manufacturer Level 8.2.2. Distributor Level 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Modality 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) & Volume (Units) Analysis By Modality, 2015 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Modality, 2023 to 2033 10.3.1. Hand Held Device 10.3.2. Benchtop Device 10.3.3. Trolley Mounted Device 10.4. Market Attractiveness Analysis By Modality 11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 11.3.1. Thyroid Uptake 11.3.2. Sentinel Lymph Node Uptake 11.3.2.1. Breast Cancer 11.3.2.2. Melanoma 11.3.2.3. Colon Cancer 11.3.2.4. NSCLC 11.3.2.5. Renal Cancer 11.3.2.6. Others 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Specialty Centers and Clinics 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2015 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East & Africa(MEA) 13.4. Market Attractiveness Analysis by Region 14. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2015 to 2022 14.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. US 14.4.1.2. Canada 14.4.2. By Modality 14.4.3. By Application 14.4.4. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Modality 14.5.3. By Application 14.5.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country Level Analysis & Forecast 14.9.1. USA Market Analysis 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Modality 14.9.1.2.2. By Application 14.9.1.2.3. By End User 14.9.2. Canada Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Modality 14.9.2.2.2. By Application 14.9.2.2.3. By End User 15. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2015 to 2022 15.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Modality 15.4.3. By Application 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Modality 15.5.3. By Application 15.5.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country Level Analysis & Forecast 15.9.1. Brazil Market Analysis 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Modality 15.9.1.2.2. By Application 15.9.1.2.3. By End User 15.9.2. Mexico Market Analysis 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Modality 15.9.2.2.2. By Application 15.9.2.2.3. By End User 15.9.3. Argentina Market Analysis 15.9.3.1. Introduction 15.9.3.2. Market Analysis and Forecast by Market Taxonomy 15.9.3.2.1. By Modality 15.9.3.2.2. By Application 15.9.3.2.3. By End User 16. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022 16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. United Kingdom. 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Russia 16.4.1.8. Rest of Europe 16.4.2. By Modality 16.4.3. By Application 16.4.4. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Modality 16.5.3. By Application 16.5.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country Level Analysis & Forecast 16.9.1. Germany Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Modality 16.9.1.2.2. By Application 16.9.1.2.3. By End User 16.9.2. Italy Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Modality 16.9.2.2.2. By Application 16.9.2.2.3. By End User 16.9.3. France Market Analysis 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Modality 16.9.3.2.2. By Application 16.9.3.2.3. By End User 16.9.4. United Kingdom. Market Analysis 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Modality 16.9.4.2.2. By Application 16.9.4.2.3. By End User 16.9.5. Spain Market Analysis 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Modality 16.9.5.2.2. By Application 16.9.5.2.3. By End User 16.9.6. BENELUX Market Analysis 16.9.6.1. Introduction 16.9.6.2. Market Analysis and Forecast by Market Taxonomy 16.9.6.2.1. By Modality 16.9.6.2.2. By Application 16.9.6.2.3. By End User 16.9.7. Russia Market Analysis 16.9.7.1. Introduction 16.9.7.2. Market Analysis and Forecast by Market Taxonomy 16.9.7.2.1. By Modality 16.9.7.2.2. By Application 16.9.7.2.3. By End User 17. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022 17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Thailand 17.4.1.3. Indonesia 17.4.1.4. Malaysia 17.4.1.5. Rest of South Asia 17.4.2. By Modality 17.4.3. By Application 17.4.4. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Modality 17.5.3. By Application 17.5.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country Level Analysis & Forecast 17.9.1. India Market Analysis 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Modality 17.9.1.2.2. By Application 17.9.1.2.3. By End User 17.9.2. Thailand Market Analysis 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Modality 17.9.2.2.2. By Application 17.9.2.2.3. By End User 17.9.3. Indonesia Market Analysis 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Modality 17.9.3.2.2. By Application 17.9.3.2.3. By End User 17.9.4. Malaysia Market Analysis 17.9.4.1. Introduction 17.9.4.2. Market Analysis and Forecast by Market Taxonomy 17.9.4.2.1. By Modality 17.9.4.2.2. By Application 17.9.4.2.3. By End User 18. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Modality 18.4.3. By Application 18.4.4. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. China Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Modality 18.8.1.2.2. By Application 18.8.1.2.3. By End User 18.8.2. Japan Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Modality 18.8.2.2.2. By Application 18.8.2.2.3. By End User 18.8.3. South Korea Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Modality 18.8.3.2.2. By Application 18.8.3.2.3. By End User 19. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022 19.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Modality 19.4.3. By Application 19.4.4. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Modality 19.5.3. By Application 19.5.4. By End User 19.6. Country Level Analysis & Forecast 19.6.1. Australia Market Analysis 19.6.1.1. Introduction 19.6.1.2. Market Analysis and Forecast by Market Taxonomy 19.6.1.2.1. By Modality 19.6.1.2.2. By Application 19.6.1.2.3. By End User 19.6.2. New Zealand Market Analysis 19.6.2.1. Introduction 19.6.2.2. Market Analysis and Forecast by Market Taxonomy 19.6.2.2.1. By Modality 19.6.2.2.2. By Application 19.6.2.2.3. By End User 20. Middle East and Africa Market Analysis 2015 to 2022and Forecast 2023 to 2033 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022 20.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Türkiye 20.4.1.3. South Africa 20.4.1.4. North Africa 20.4.1.5. Rest of Middle East and Africa 20.4.2. By Modality 20.4.3. By Application 20.4.4. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Modality 20.5.3. By Application 20.5.4. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country Level Analysis & Forecast 20.9.1. GCC Countries Market Analysis 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Modality 20.9.1.2.2. By Application 20.9.1.2.3. By End User 20.9.2. Türkiye Market Analysis 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Modality 20.9.2.2.2. By Application 20.9.2.2.3. By End User 20.9.3. South Africa Market Analysis 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Modality 20.9.3.2.2. By Application 20.9.3.2.3. By End User 20.9.4. North Africa Market Analysis 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Modality 20.9.4.2.2. By Application 20.9.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. Regional footprint of Players 21.4.2. Product footprint of Players 21.4.3. Channel Footprint of Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Deep Dive 22.2.1. Biodex Medical Systems, Inc. 22.2.1.1. Overview 22.2.1.2. Product Portfolio 22.2.1.3. Key Financial 22.2.1.4. Sales Footprint 22.2.1.5. SWOT Analysis 22.2.1.6. Strategy Overview 22.2.1.6.1. Marketing Strategies 22.2.1.6.2. Product Strategies 22.2.1.6.3. Channel Strategies 22.2.2. CAPINTEC, INC. 22.2.2.1. Overview 22.2.2.2. Product Portfolio 22.2.2.3. Key Financial 22.2.2.4. Sales Footprint 22.2.2.5. SWOT Analysis 22.2.2.6. Strategy Overview 22.2.2.6.1. Marketing Strategies 22.2.2.6.2. Product Strategies 22.2.2.6.3. Channel Strategies 22.2.3. Crystal Photonics GmBH 22.2.3.1. Overview 22.2.3.2. Product Portfolio 22.2.3.3. Key Financial 22.2.3.4. Sales Footprint 22.2.3.5. SWOT Analysis 22.2.3.6. Strategy Overview 22.2.3.6.1. Marketing Strategies 22.2.3.6.2. Product Strategies 22.2.3.6.3. Channel Strategies 22.2.4. Devicor Medical Products, Inc (Mammotome) 22.2.4.1. Overview 22.2.4.2. Product Portfolio 22.2.4.3. Key Financial 22.2.4.4. Sales Footprint 22.2.4.5. SWOT Analysis 22.2.4.6. Strategy Overview 22.2.4.6.1. Marketing Strategies 22.2.4.6.2. Product Strategies 22.2.4.6.3. Channel Strategies 22.2.5. Dilon Technologies, Inc 22.2.5.1. Overview 22.2.5.2. Product Portfolio 22.2.5.3. Key Financial 22.2.5.4. Sales Footprint 22.2.5.5. SWOT Analysis 22.2.5.6. Strategy Overview 22.2.5.6.1. Marketing Strategies 22.2.5.6.2. Product Strategies 22.2.5.6.3. Channel Strategies 22.2.6. Gamma Medical Technology 22.2.6.1. Overview 22.2.6.2. Product Portfolio 22.2.6.3. Key Financial 22.2.6.4. Sales Footprint 22.2.6.5. SWOT Analysis 22.2.6.6. Strategy Overview 22.2.6.6.1. Marketing Strategies 22.2.6.6.2. Product Strategies 22.2.6.6.3. Channel Strategies 22.2.7. Intramedical Imaging 22.2.7.1. Overview 22.2.7.2. Product Portfolio 22.2.7.3. Key Financial 22.2.7.4. Sales Footprint 22.2.7.5. SWOT Analysis 22.2.7.6. Strategy Overview 22.2.7.6.1. Marketing Strategies 22.2.7.6.2. Product Strategies 22.2.7.6.3. Channel Strategies 22.2.8. Intramedical Imaging 22.2.8.1. Overview 22.2.8.2. Product Portfolio 22.2.8.3. Key Financial 22.2.8.4. Sales Footprint 22.2.8.5. SWOT Analysis 22.2.8.6. Strategy Overview 22.2.8.6.1. Marketing Strategies 22.2.8.6.2. Product Strategies 22.2.8.6.3. Channel Strategies 22.2.9. KUB Technologies 22.2.9.1. Overview 22.2.9.2. Product Portfolio 22.2.9.3. Key Financial 22.2.9.4. Sales Footprint 22.2.9.5. SWOT Analysis 22.2.9.6. Strategy Overview 22.2.9.6.1. Marketing Strategies 22.2.9.6.2. Product Strategies 22.2.9.6.3. Channel Strategies 22.2.10. L'ACN - l'Accessorio Nucleare 22.2.10.1. Overview 22.2.10.2. Product Portfolio 22.2.10.3. Key Financial 22.2.10.4. Sales Footprint 22.2.10.5. SWOT Analysis 22.2.10.6. Strategy Overview 22.2.10.6.1. Marketing Strategies 22.2.10.6.2. Product Strategies 22.2.10.6.3. Channel Strategies 22.2.11. Mammotome 22.2.11.1. Overview 22.2.11.2. Product Portfolio 22.2.11.3. Key Financial 22.2.11.4. Sales Footprint 22.2.11.5. SWOT Analysis 22.2.11.6. Strategy Overview 22.2.11.6.1. Marketing Strategies 22.2.11.6.2. Product Strategies 22.2.11.6.3. Channel Strategies 22.2.12. NUCLEAR MEDSYSTEMS 22.2.12.1. Overview 22.2.12.2. Product Portfolio 22.2.12.3. Key Financial 22.2.12.4. Sales Footprint 22.2.12.5. SWOT Analysis 22.2.12.6. Strategy Overview 22.2.12.6.1. Marketing Strategies 22.2.12.6.2. Product Strategies 22.2.12.6.3. Channel Strategies 22.2.13. Oncovision 22.2.13.1. Overview 22.2.13.2. Product Portfolio 22.2.13.3. Key Financial 22.2.13.4. Sales Footprint 22.2.13.5. SWOT Analysis 22.2.13.6. Strategy Overview 22.2.13.6.1. Marketing Strategies 22.2.13.6.2. Product Strategies 22.2.13.6.3. Channel Strategies 22.2.14. Southern Scientific Ltd. 22.2.14.1. Overview 22.2.14.2. Product Portfolio 22.2.14.3. Key Financial 22.2.14.4. Sales Footprint 22.2.14.5. SWOT Analysis 22.2.14.6. Strategy Overview 22.2.14.6.1. Marketing Strategies 22.2.14.6.2. Product Strategies 22.2.14.6.3. Channel Strategies 23. Assumptions and Acronyms Used 24. Research Methodolog
Explore Healthcare Insights
View Reports
Gamma Probe Devices Market
